semaglutide week 2 results My 6-Week Journey with Semaglutide: Robert Hernandez Wegovy Weight Loss | Week

Hypoglycaemia concerns: Although uncommon with Mounjaro monotherapy, patients using the medication alongside other glucose-lowering agents (particularly insulin or sulphonylureas) may experience nocturnal hypoglycaemia, which can cause night-time awakening, sweating, and disrupted sleep architecture

If you take other morning medications, such as thyroid medication, that also requires to be taken on an empty stomach without anything else to allow for proper absorption, then this could result in an hour or longer to stack these medications each morning

Furthermore, the option to continue or initiate new AD medication during the trial, including the amyloid lowering monoclonal antibodies, was not a randomization stratification factor and may therefore act as a confounding factor if their use across treatment arms is unequal

Generic drug manufacturers could challenge existing patents in court, potentially bringing generic versions to market sooner

Anish Y

Navigating the Balance: Risks of Glucagon-Like-Peptide-1 Receptor Agonist and Levothyroxine Co-Administration